Enovis (ENOV) FCF Margin Growth (3y) (2013 - 2026)
Enovis (ENOV) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 76.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 76.00 |
| Dec 31, 2025 | 2,341.00 |
| Oct 3, 2025 | 568.00 |
| Jul 4, 2025 | 1,290.00 |
| Apr 4, 2025 | 223.00 |
| Dec 31, 2024 | -1,017.00 |
| Sep 27, 2024 | -1,847.00 |
| Jun 28, 2024 | -2,238.00 |
| Mar 29, 2024 | -3,339.00 |
| Dec 31, 2023 | -265.00 |
| Sep 29, 2023 | -510.00 |
| Jun 30, 2023 | -488.00 |
| Mar 31, 2023 | -874.00 |
| Dec 31, 2022 | -2,232.00 |
| Sep 30, 2022 | -261.00 |
| Jul 1, 2022 | -1,704.00 |
| Apr 1, 2022 | 387.00 |
| Dec 31, 2021 | -29.00 |
| Oct 1, 2021 | 907.00 |
| Jul 2, 2021 | 1,233.00 |